Additionally, it was unclear whether molecular aberrations aside from those known to be associated with clonal expansion of eosinophils (PDGFR and FGFR1 fusions and JAK2 variations) present in our cohort of patients with HES represented actual clonal expansion vs concomitant CHIP. This evidence concerns the gene JAK2 and hypereosinophilic syndrome.